Asia-Pacific Americas Africa Europe Middle East

IMEXPHARM CORPORATION

Company Profile:



Business Type: Manufacturer (Factory)

Company Profile:

Imexpharm Corporation is a leading pharmaceutical manufacturer in Vietnam, established in 1977. The company specializes in the research, development, production, and distribution of high-quality pharmaceutical products. Imexpharm operates multiple modern manufacturing facilities that strictly adhere to EU-GMP (European Good Manufacturing Practice) standards. Their product portfolio includes a wide range of prescription drugs, antibiotics, and healthcare supplements. As a vertically integrated manufacturer, the company focuses on R&D and advanced production technologies to serve both domestic and international markets.

Enterprise Products

Imexpharm Corporation produces and sells a wide range of pharmaceutical products, primarily categorized as follows:

Antibiotics

Oral and injectable antibiotics, including Penicillins, Cephalosporins, and Carbapenems.

Analgesics and Antipyretics

Medications for pain relief and fever reduction.

Gastrointestinal Drugs

Treatments for digestive system disorders, including antacids and anti-diarrheal agents.

Respiratory Drugs

Medications for coughs, colds, and respiratory inflammation.

Cardiovascular Drugs

Treatments for hypertension and related heart conditions.

Nutritional Supplements and Vitamins

Various vitamin formulations and health supplements to support general well-being.

Dermatological Products

Topical creams and ointments for skin conditions.

Ophthalmological Products

Eye drops and related ocular treatments.

Specialty Medicines

Various therapeutic agents targeting specific medical conditions, often produced under international quality standards such as EU-GMP.

Business Registration Information:

Manager:

Tran Thi Dao

Phone:

No Data

E-mail:

imexpharm@imexpharm.com

Official Website:
Address:

04 Street 30/4, Ward 1, Cao Lanh City, Dong Thap Province, Vietnam

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.